Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

In the latest trading session, Pfizer (PFE) closed at $22.15 ... these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this ...

The market seems to be waking up on Pfizer's recovery prospects ... particularly evidenced by its recent quarter performance - I think that the stock should continue to be rated as a "Buy".

Pfizer (PFE) closed at $29.74 in the latest ... these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a ...

The remarkable improvement was driven by the strong performance of Pfizer's core portfolio ... and then choose between a market order or a limit order to buy the stock. To sell shares of Pfizer ...

Pfizer PFE will report its first-quarter earnings on April 29, before market open ... The healthcare bellwether’s performance has been solid, with the company exceeding earnings expectations ...

The drugmaker's stock has dropped by 15.91% in the past month, falling short of the Medical sector's loss of 8.46% and the S&P 500's loss of 6.3%. The investment community will be paying close ...